Panagiotis Kourtesis

Director, Early Global Development Scientist - Oncology R&d at AstraZeneca

Panagiotis Kourtesis, PhD, currently serves as the Director of Early Global Development Scientist in Oncology R&D at AstraZeneca since October 2018. Prior experience includes roles as Associate Director and Senior Manager in Early Clinical Development at AbbVie, as well as positions at Teva/Actavis Generics, ALAPIS, ICON Clinical Research, and Regulon, Inc., where expertise in clinical research and bioinformatics was developed. Panagiotis earned a PhD in Chemistry from American University and has completed post-doctoral research at the National Heart, Lung, and Blood Institute. Educational background also includes a Master of Science and a Bachelor of Science in Chemistry from William & Mary, along with a high school diploma from Hellenic American Educational Foundation Athens College.

Links

Previous companies

AbbVie logo
ICON logo

Timeline

  • Director, Early Global Development Scientist - Oncology R&d

    July, 2021 - present

  • Associate Director, Early Clinical Development Scientist – Oncology R&d

    May, 2021

  • Senior Manager, Early Clinical Development Scientist - Oncology R&d

    October, 2018